153 related articles for article (PubMed ID: 24792481)
1. Risk of cutaneous malignant melanoma in patients with celiac disease: a population-based study.
Lebwohl B; Eriksson H; Hansson J; Green PH; Ludvigsson JF
J Am Acad Dermatol; 2014 Aug; 71(2):245-8. PubMed ID: 24792481
[TBL] [Abstract][Full Text] [Related]
2. Smallpox and BCG vaccination in childhood and cutaneous malignant melanoma in Danish adults followed from 18 to 49 years.
Rieckmann A; Meyle KD; Rod NH; Baker JL; Benn CS; Aaby P; Sørup S
Vaccine; 2019 Oct; 37(44):6730-6736. PubMed ID: 31537447
[TBL] [Abstract][Full Text] [Related]
3. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
4. Risk of stroke in 28,000 patients with celiac disease: a nationwide cohort study in Sweden.
Ludvigsson JF; West J; Card T; Appelros P
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):860-7. PubMed ID: 21733721
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis in a nationwide cohort study of patients with celiac disease.
Ludvigsson JF; Lindelöf B; Zingone F; Ciacci C
J Invest Dermatol; 2011 Oct; 131(10):2010-6. PubMed ID: 21654830
[TBL] [Abstract][Full Text] [Related]
6. Type 1 Diabetes, Celiac Disease, and Neuropathy-A Nationwide Cohort Study.
Thawani S; Brannagan TH; Lebwohl B; Mollazadegan K; Green PHR; Ludvigsson JF
J Clin Neuromuscul Dis; 2017 Sep; 19(1):12-18. PubMed ID: 28827484
[TBL] [Abstract][Full Text] [Related]
7. A large nationwide population-based case-control study of the association between intussusception and later celiac disease.
Ludvigsson JF; Nordenskjöld A; Murray JA; Olén O
BMC Gastroenterol; 2013 May; 13():89. PubMed ID: 23679928
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of cataract among 28,000 patients with celiac disease.
Mollazadegan K; Kugelberg M; Lindblad BE; Ludvigsson JF
Am J Epidemiol; 2011 Jul; 174(2):195-202. PubMed ID: 21624959
[TBL] [Abstract][Full Text] [Related]
9. Season of birth and other perinatal risk factors for melanoma.
Crump C; Sundquist K; Sieh W; Winkleby MA; Sundquist J
Int J Epidemiol; 2014 Jun; 43(3):793-801. PubMed ID: 24453238
[TBL] [Abstract][Full Text] [Related]
10. Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease.
Ludvigsson JF; James S; Askling J; Stenestrand U; Ingelsson E
Circulation; 2011 Feb; 123(5):483-90. PubMed ID: 21262996
[TBL] [Abstract][Full Text] [Related]
11. Risk of Clostridium difficile Infection in Patients With Celiac Disease: A Population-Based Study.
Lebwohl B; Nobel YR; Green PHR; Blaser MJ; Ludvigsson JF
Am J Gastroenterol; 2017 Dec; 112(12):1878-1884. PubMed ID: 29087398
[TBL] [Abstract][Full Text] [Related]
12. Risk of skin disorders in patients with celiac disease: A population-based cohort study.
Lebwohl B; Söderling J; Roelstraete B; Lebwohl MG; Green PHR; Ludvigsson JF
J Am Acad Dermatol; 2021 Dec; 85(6):1456-1464. PubMed ID: 33144153
[TBL] [Abstract][Full Text] [Related]
13. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma.
Wei Q; Lee JE; Gershenwald JE; Ross MI; Mansfield PF; Strom SS; Wang LE; Guo Z; Qiao Y; Amos CI; Spitz MR; Duvic M
J Natl Cancer Inst; 2003 Feb; 95(4):308-15. PubMed ID: 12591987
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
[TBL] [Abstract][Full Text] [Related]
15. Does urticaria risk increase in patients with celiac disease? A large population-based cohort study.
Ludvigsson JF; Lindelöf B; Rashtak S; Rubio-Tapia A; Murray JA
Eur J Dermatol; 2013; 23(5):681-7. PubMed ID: 24135663
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects.
Krüger S; Garbe C; Büttner P; Stadler R; Guggenmoos-Holzmann I; Orfanos CE
J Am Acad Dermatol; 1992 Jun; 26(6):920-6. PubMed ID: 1607409
[TBL] [Abstract][Full Text] [Related]
17. Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register.
Lyth J; Mikiver R; Nielsen K; Isaksson K; Ingvar C
Eur J Cancer; 2016 May; 59():171-178. PubMed ID: 27046697
[TBL] [Abstract][Full Text] [Related]
18. Does celiac disease influence survival in lymphoproliferative malignancy?
Ludvigsson JF; Lebwohl B; Rubio-Tapia A; Murray JA; Green PH; Ekbom A; Granath F
Eur J Epidemiol; 2013 Jun; 28(6):475-83. PubMed ID: 23463575
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate treatment for patients with psoriasis and risk of cutaneous melanoma: a nested case-control study.
Polesie S; Gillstedt M; Paoli J; Osmancevic A
Br J Dermatol; 2020 Oct; 183(4):684-691. PubMed ID: 31981364
[TBL] [Abstract][Full Text] [Related]
20. Do perinatal and early life exposures influence the risk of malignant melanoma? A Northern Ireland birth cohort analysis.
O'Rorke MA; Black C; Murray LJ; Cardwell CR; Gavin AT; Cantwell MM
Eur J Cancer; 2013 Mar; 49(5):1109-16. PubMed ID: 23146960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
